Daunorubicin | search
Click here to view Daunorubicin news from 60+ newspapers.
Bookmark or Share- Daunorubicin: Uses, Interactions, Mechanism of Action - DrugBank OnlineDaunorubicin is an anthracycline aminoglycoside used to induce remission of nonlymphocytic leukemia and acute lymphocytic leukemia. Brand Names. Cerubidine, Vyxeos. Generic Name. Daunorubicin. DrugBank Accession Number. DB00694. Background.
- Daunorubicin | Leukemia and Lymphoma SocietyDaunorubicin is FDA approved for use in combination with other approved anticancer drugs for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphoblastic leukemia of children and adults.
- Daunorubicin - WikipediaDaunorubicin, also known as daunomycin, is a chemotherapy medication used to treat cancer. Specifically it is used for acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), and Kaposi's sarcoma. It is administered by injection into a vein.
- Daunorubicin Uses, Side Effects & Warnings - Drugs.comWhat is daunorubicin? Daunorubicin is used in combination chemotherapy to treat leukemia. Daunorubicin may also be used for purposes not listed in this medication guide. Daunorubicin side effects. Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
- Daunorubicin | Macmillan Cancer SupportDaunorubicin is used to treat acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL). Learn more about it.
More
